The best biopharma M&A deals
Jun 28, 2024•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
At Fierce Biotech, we love a big M&A deal, but valuation does not always equal the most exciting.
In this week's episode of "The Top Line," Fierce Biotech’s Annalee Armstrong and James Waldron discuss what they think are the best and smartest acquisitions in recent years.
From obesity to radiopharmaceuticals, they give you the Fierce Biotech team’s thoughts on who got the best deal.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
For the best experience, listen in Metacast app for iOS or Android